Remaining life original costnbspaccumunbspamorti fair value


As of December 31, 2012, NPR, Inc. has patents and trademarks on its balance sheet. NPR has decided it does not want to use the qualitative assessment option for impairment testing on its trademark for US GAAP. Neither asset has been previously impaired. Information for these assets as of December 31, 2012, is as follows: Remaining life Original cost Accumu. Amorti.* Fair value Selling costs Present value of future cash flows Summation of future, undiscounted cash flows Patent 10 years $200,000 $100,000 $80,000 $2,000 $85,000 $95,000 Trademark Indefinite $250,000 - $225,000 Insignificant $220,000 $240,000 As of December 31, 2013, the fair value, selling costs and the present value of future cash flows of the patent had not changed. The sum of future undiscounted cash flows for the patent is now $90,000. The fair value of the trademark had increased to $230,000 and the present value of the future cash flows for the trademark has increased to $225,000. Selling costs are still insignificant. The sum of future cash flows is still $240,000. Please provide any necessary calculations and journal entries for these assets on NPR Inc.'s balance sheet using both IFRS and US GAAP for 2012 and 2013.

Request for Solution File

Ask an Expert for Answer!!
Financial Accounting: Remaining life original costnbspaccumunbspamorti fair value
Reference No:- TGS01215865

Expected delivery within 24 Hours